-
4th Sep 2012, 11:46 AM
#1
IMP Transfer from one study site to another
I want to know if there is a guidance or regulation in UK or EU which defines under which circumstances a sponsor is allowed to transfer IMP from one site to another during the course of a clinical trial. If so can anyone please provide a link to such a guidance or regulation. If there is no guidance or regulation, how can a sponsor define such a site to site transfer of IP in its SOPs.
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules